Dr Adrian Hunt is an experienced medical retina specialist with extensive expertise in the diagnosis and treatment of macular and retinal vascular diseases. He has a strong background in clinical care, research and medical education, and confines his practice at Eye Associates exclusively to medical retina.

Dr Hunt completed his MBBS in 1995 at the University of Sydney, based at Royal Prince Alfred Hospital, and later obtained a Master of Biomedical Engineering from the University of New South Wales. His interest in retinal disease began early in his career while working at The Children’s Hospital at Westmead, where he investigated a rare paediatric retinal condition and published his findings in the British Journal of Ophthalmology. He completed specialty ophthalmology training at Sydney Eye Hospital and became a Fellow of the Royal Australian and New Zealand College of Ophthalmologists in 2006.

In 2007, Dr Hunt returned to Westmead Hospital to undertake a retinal fellowship under Professor Paul Mitchell, working with the Westmead Millennium Institute and Centre for Vision Research. His fellowship focused on the management of age-related macular degeneration (AMD), diabetic retinopathy, retinal vascular disease and systemic conditions affecting the eye.

Dr Hunt is a Consultant Ophthalmologist at Westmead Hospital, where he contributes to the training of future ophthalmologists. He is an active member of the Australian and New Zealand Society of Retinal Specialists (ANZSRS) and has authored, presented and reviewed peer-reviewed research at both national and international levels. He participates in major international clinical studies into emerging retinal therapies at Westmead Hospital and Eye Associates.

He is also affiliated with the Save Sight Institute, University of Sydney, where he is undertaking a PhD under the supervision of Professor Mark Gillies, focusing on retinal vein occlusion.

Dr Hunt has particular expertise in advanced diagnostic techniques, retinal laser therapy and intravitreal injection treatment for macular disease. His clinical approach is grounded in evidence-based care, precision and a strong commitment to achieving the best possible visual outcomes for his patients.